Table 5 Prevalence of CKD in Bangladesh, Pakistan and Nepal
From: Prevalence of chronic kidney disease in South Asia: a systematic review
Author [ref.], year | Assessment of Kidney Function | Prevalence of CKD | ||
|---|---|---|---|---|
Bangladesh: | ||||
 Anand et al. [25], 2014 | Spot quantitative urine protein and eGFR (CKD-EPI) | Overall: 26% | Age specific prevalence: Not Mentioned | |
Gender specific prevalence: Male: 24.7% Female: 28% | ||||
 Fatema et al. [26], 2013 | Spot quantitative urine protein and eGFR (MDRD) | Overall: 12.8% | Age specific prevalence: | |
Not Mentioned | ||||
Gender specific prevalence: | ||||
Not Mentioned | ||||
 Huda et al. [27], 2012 | Spot quantitative urine protein, creatinine clearance and eGFR (CG/BSA & MDRD) | Overall: 13.1% (MDRD), 16% (CG/BSA) | Age specific prevalence (MDRD): | |
25–40 Years: 10.7% | ||||
> 40 Years: 16% | ||||
Gender specific prevalence (MDRD): Male: 14.7% Female: 12.3% | ||||
Nepal: | ||||
 Sharma et al. [32], 2013 | Spot quantitative urine protein and eGFR (MDRD) | Overall: 10.6% | Age specific prevalence: | |
Age in years | Prevalence | |||
20–39 | 3.4% | |||
40–59 | 11.4% | |||
≥ 60 | 30.5% | |||
Gender specific prevalence: Not Mentioned | ||||
Pakistan: | ||||
 Alam et al. [28], 2014 | Spot quantitative urine protein and eGFR (MDRD) | Overall: 16.6% | Age specific prevalence: | |
Age in Years | Prevalence | |||
<  30 | 10.5% | |||
30–50 | 12.7% | |||
> 50 | 43.6% | |||
Gender specific prevalence: Male: 20.6% Female: 14.2% | ||||
 Imran et al. [29], 2015 | eGFR (CKD-EPI) | Overall: 25.6% | Age specific prevalence: Not Mentioned | |
Gender specific prevalence: Male: 26.3% Female: 22.4% | ||||
 Jafar et al. [30], 2005 | Creatinine clearance and eGFR (MDRD) | Overall: 29.9% | Age specific prevalence: Not Mentioned | |
Gender specific prevalence: Male: 26.7% Female: 32.5% | ||||
 Jessani et al. [31], 2014 | Spot quantitative urine protein and eGFR (CKD-EPI Pakistan equation) | Overall: 12.5% | Age specific prevalence: Not Mentioned | |
Gender specific prevalence: Male: 11.6% Female: 13.3% | ||||